SIGMOID SINUS THROMBOSIS

SIGMOID SINUS THROMBOSIS was reported 66 times

SIGMOID SINUS THROMBOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-6 Antagonist [EPC] 2 0.0031
1 Amyloid Beta-directed Antibody [EPC] 1 0.0003
2 Purine Antimetabolite [EPC] 18 0.0002
3 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
4 Echinocandin Antifungal [EPC] 1 0.0001
5 Penem Antibacterial [EPC] 4 0.0001
6 Integrin Receptor Antagonist [EPC] 9 0.0001
7 Aminosalicylate [EPC] 9 0.0001
8 Catecholamine [EPC] 7 0.0001
9 Azole Antifungal [EPC] 13 0.0001
10 Androgen [EPC] 2 0.0001
11 Calcineurin Inhibitor Immunosuppressant [EPC] 9 0.0001
12 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
13 Interleukin-12 Antagonist [EPC] 4 0.0000
14 Interleukin-23 Antagonist [EPC] 4 0.0000
15 Topoisomerase Inhibitor [EPC] 2 0.0000
16 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
17 Corticosteroid [EPC] 27 0.0000
18 Tumor Necrosis Factor Blocker [EPC] 19 0.0000
19 Antirheumatic Agent [EPC] 2 0.0000
20 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
21 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
22 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
24 Platinum-based Drug [EPC] 3 0.0000
25 Factor Xa Inhibitor [EPC] 3 0.0000
26 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
27 Alkylating Drug [EPC] 2 0.0000
28 Fluoroquinolone Antibacterial [EPC] 1 0.0000
29 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
30 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
31 Leukocyte Growth Factor [EPC] 1 0.0000
32 Janus Kinase Inhibitor [EPC] 1 0.0000
33 Estrogen [EPC] 1 0.0000
34 Kinase Inhibitor [EPC] 2 0.0000
35 Progestin [EPC] 1 0.0000
36 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
37 Thalidomide Analog [EPC] 1 0.0000
38 Platelet Aggregation Inhibitor [EPC] 1 0.0000
39 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000